HARBOUR ANTIBODIES
Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands) for engineering mice to produce high affinity human antibodies. The company has developed two types of human immunoglobulin gene transgenic mice: mice that generate “conventional” tetrameric antibodies comprising two heavy and two light immunoglobulin chains (H2L2); and alternatively, mice that generate heavy chain... only antibodies comprising two immunoglobulin heavy chains with no light chains (HCAbs). Availability of HCAbs facilitates the generation of soluble human VH domains (human heavy chain variable region domains), the minimal immunoglobulin recognition unit, and thus the construction of novel multi-functional molecules comprising either two (or more) VH domains or one VH domain coupled to other molecules. Both Harbour transgenic mouse lines are now available to licensing partners.
HARBOUR ANTIBODIES
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2006-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.harbourantibodies.com
Total Employee:
1+
Status:
Active
Contact:
617.203.2182
Total Funding:
2.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache Wordpress Plugins Euro
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Current Advisors List
Current Employees Featured
Founder
Investors List
Atlas Venture
Atlas Venture investment in Series A - Harbour Antibodies
Official Site Inspections
http://www.harbourantibodies.com Semrush global rank: 9.56 M Semrush visits lastest month: 141
- Host name: 192-254-190-144.unifiedlayer.com
- IP address: 192.254.190.144
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
